Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.

BMC Infect Dis · 2018 · PMC6029116 · PMID 29970037

Europe PMC DOI

hedged sentences

0.0810

closest p · 1.6× alpha

0.0810

boldest claim

The sentences

borderline significanceP = 0.081so close (0.05 < p ≤ 0.1)

14.8%, P = 0.005) were independent risk factors for the rate of death in the TB-HBV group, and HBV DNA > 20,000 IU/ml had borderline significance (44.1% vs. 20.8%, P = 0.081).

also in 7,017 other papers

an increasing trendno p-value reported

Only five patients had documented HBV DNA levels before anti-TB treatment had been initiated, and there was an increasing trend in HBV DNA levels after receiving anti-TB treatment.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.